CODA Biotherapeutics Announces Preclinical Data From Epilepsy Program to be Presented at American Society of Gene & Cell Therapy 25th Annual Meeting
- Thursday, May 5, 2022, 7:04
- Finance
- Add a comment
Research details assessment and selection of AAV regulatory cassettes that drive optimal expression of Company’s novel engineered ligand-gated ion channel for the treatment of focal epilepsy Findings inform selection process of final development candidate SOUTH SAN FRANCISCO, Calif., May…
About the Author
adminasapcorp has written 41546 stories on this site.